JPS6332049B2 - - Google Patents
Info
- Publication number
- JPS6332049B2 JPS6332049B2 JP56021686A JP2168681A JPS6332049B2 JP S6332049 B2 JPS6332049 B2 JP S6332049B2 JP 56021686 A JP56021686 A JP 56021686A JP 2168681 A JP2168681 A JP 2168681A JP S6332049 B2 JPS6332049 B2 JP S6332049B2
- Authority
- JP
- Japan
- Prior art keywords
- powder
- cement
- calcium
- paste
- hardening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000004568 cement Substances 0.000 claims description 53
- 239000000843 powder Substances 0.000 claims description 49
- 239000000463 material Substances 0.000 claims description 37
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 22
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 15
- 239000011575 calcium Substances 0.000 claims description 15
- 229910052791 calcium Inorganic materials 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 5
- 239000011812 mixed powder Substances 0.000 claims description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 3
- 229920000084 Gum arabic Polymers 0.000 claims description 3
- 241000978776 Senegalia senegal Species 0.000 claims description 3
- 239000000205 acacia gum Substances 0.000 claims description 3
- 235000010489 acacia gum Nutrition 0.000 claims description 3
- 229910001424 calcium ion Inorganic materials 0.000 claims description 3
- 238000009792 diffusion process Methods 0.000 claims description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 3
- 239000004115 Sodium Silicate Substances 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 150000004665 fatty acids Chemical class 0.000 claims description 2
- 239000000025 natural resin Substances 0.000 claims description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims description 2
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052911 sodium silicate Inorganic materials 0.000 claims description 2
- 239000000203 mixture Substances 0.000 description 10
- 210000004262 dental pulp cavity Anatomy 0.000 description 8
- 239000000945 filler Substances 0.000 description 7
- 230000035876 healing Effects 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 238000005259 measurement Methods 0.000 description 5
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 4
- 239000000920 calcium hydroxide Substances 0.000 description 4
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 4
- 239000000292 calcium oxide Substances 0.000 description 4
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 4
- OKJPEAGHQZHRQV-UHFFFAOYSA-N iodoform Chemical compound IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 4
- 238000004898 kneading Methods 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000002631 root canal filling material Substances 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000003827 pulp capping and pulpectomy agent Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- XFWJKVMFIVXPKK-UHFFFAOYSA-N calcium;oxido(oxo)alumane Chemical compound [Ca+2].[O-][Al]=O.[O-][Al]=O XFWJKVMFIVXPKK-UHFFFAOYSA-N 0.000 description 1
- 229910052593 corundum Inorganic materials 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000011268 retreatment Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229910001845 yogo sapphire Inorganic materials 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Landscapes
- Dental Preparations (AREA)
Description
本発明は、歯科治療用セメント材に関し、更に
詳しくは歯髄覆罩剤、根管充填剤、シーリング
剤、骨欠損修復剤等の用途に適したアルミナセメ
ントを主成分とする歯科治療用セメント材に関す
る。
歯科治療分野に於ては、歯髄組織なきあとの歯
髄腔を閉塞して感染根管の治癒を図る根管充填
剤、或は窩洞形成の場合の歯髄の保護を図る歯髄
覆罩剤等として、種々の材料のものが使用されて
いる。しかしながら、現在までのところ充分満足
しうるものは見当らないのが実情である。
今、根管充填剤を例にとつて説明すると、これ
に適する材料は、一般に無刺激であること、無毒
性であること、組織との親和性及び根管壁との適
合性があること、抗菌作用ないし治癒作用がある
こと、強度が大きいこと、体積変化を生じないこ
と、組織液に不溶であること、可撒性があり再治
療可能であること、造影性があること、取扱いが
容易であること、等の諸条件を満足することが理
想である。このうち造影性については適宜の造影
剤を混入すれば解決できるが、その他の条件は根
管充填剤自体の特性に依存するところが大きいも
のである。
例えば、従来より広く使用されている根管充填
剤の代表的なものの一つに、酸化亜鉛・ユージノ
ール系の材料を使用したものがあるが、これは酸
性材料であるため、刺激性があり且つ治癒作用の
ないものである。亦もう一つの代表的なものに、
水酸化カルシウム系材料を使用したものがある
が、これは強度が小さく、しかも強アルカリ性材
料料であるから組織をいためる惧れがあり、亦経
時的に炭酸カルシウムに変質するものである。そ
の他、ホルムアルデヒド系材料、或はヨードホル
ム系材料等を用いた根管充填剤も使用されている
が、いずれも一長一短があり、このように上記の
条件を充分満足し得るものは未だ開発されておら
ないのである。
本発明は、叙上の事情に鑑みてなされたもので
あつて、歯科分野の関係者のだれもが予想しなか
つた工業用アルミナセメントの利用可能性に注目
し、種々研究を重ねてこのアルミナセメントを歯
科治療用材料に適するよう改良することに成功し
たものである。
即ち、本発明は、アルミナセメント粉と、この
セメント粉100重量部に対し1〜50重量部の割合
のカルシウム系粉末硬化剤と、カルシウムイオン
の拡散を抑制し得る硬化遅延剤とを必須成分とす
る歯科治療用セメント材である。
主成分であるアルミナセメント粉は、酸化アル
ミニウムが約80重量%、酸化カルシウムが約20重
量%の割合とされたアルミン酸カルシウム
(CaO・Al2O3)から成るもので、市販の工業用
セメントとして容易且つ安価に入手できるもので
ある。
亦、本発明に使用するカルシウム系粉末硬化剤
は、例えば水酸化カルシウム、塩化カルシウムも
しくは酸化カルシウムの粉末であつて、殊に水酸
化カルシウム粉末が好適に使用出来る。斯るカル
シウム系粉末硬化剤は、上記の如く、アルミナセ
メント粉100重量部に対して1〜50重量部の割合
とする必要がある。これは、1重量部未満では、
セメント材が硬化するのに長時間を要し且つ硬化
物の強度も低下するので、歯髄覆罩剤や根管充填
剤等の治療用材料としては不適なものとなり、逆
に50重量部を超えれば、硬化速度やアルカリ性が
大きくなり過ぎるので、取扱い性や治癒効果の面
でかえつてマイナスとなるからである。このよう
なことから、硬化時間、強度、治癒効果等を比較
衡量した場合、カルシウム系粉末硬化剤の割合を
20重量部程度とするのが最適であり、この割合と
するときは、強度及び治癒効果が大でしかも取扱
い性の良好なセメント材が得られる。
一方、本発明に使用する硬化遅延剤は、アルミ
ナセメントの硬化に関与するカルシウムイオンの
拡散を抑制しうるポリビニルアルコール、ポリビ
ニルピロリドン、アラビアゴム、ポリアクリル酸
ソーダ、ケイ酸ナトリウム、グリセリンその他の
低分子脂肪酸もしくは親水性天然樹脂であつて、
これらは単独で、或は二種以上混合して使用され
る。斯る硬化遅延剤は、アルミナセメント粉100
重量部に対し1〜20重量部の割合とするのが望ま
しい。もし、1重量部未満であれば硬化遅延作用
が不充分なためセメント材が極く短時間のうちに
硬化するようになり、逆に20重量部を超えると硬
化遅延作用が過剰なため硬化に長時間を要するよ
うになり、いずれも歯科治療用セメント材には不
向きな組成物となるからである。
本発明セメント材は、上記の如きアルミナセメ
ント粉、カルシウム系粉末硬化剤及び硬化遅延剤
を必須成分とするものであるが、必要に応じて、
例えば強度を高めるために酸化チタン粉末、酸化
アルミニウム粉末などの充填剤を加えたり、ヨー
ドホルム、ポラホルムなどの防腐剤を加えたり、
公知の各種造影剤や消炎剤を加えたりすることも
勿論可能である。このような副次成分の割合につ
いては特に制限はなく、適宜決定すればよい。
以上の如き本発明歯科治療用セメント材は、使
用前の保存形態によつて、次の四つのタイプに分
けられる。
第1のタイプのものは、アルミナセメント粉及
びカルシウム系粉末硬化剤を少なくとも含む混合
粉末と、少なくとも硬化遅延剤を水等に溶解もし
くは分散させた液とに分けて保存する、パウダ
ー・リキツド系の組成物であり、第2のタイプの
ものは、アルミナセメント粉を少なくとも含む粉
末と、少なくとも硬化遅延剤の溶解もしくは分散
液にカルシウム系粉末硬化剤を添加練合したペー
ストとに分けて保存する、パウダー・ペースト系
の組成物であり、第3のタイプのものは、少なく
ともアルミナセメント粉及びカルシウム系粉末硬
化剤をグリセリン等に添加練合したペーストと、
少なくとも硬化遅延剤を溶解もしくは分散させた
液とに分けて保存する、ペースト・リキツドタイ
プの組成物であり、第4のタイプのものは、少な
くともアルミナセメント粉をグリセリン等に添加
練合したペーストと、少なくとも硬化遅延剤の溶
解もしくは分散液にカルシウム系粉末硬化剤を添
加練合したペーストとに分けて保存するペース
ト・ペースト系のセメント材である。而して、前
述の副次成分を加える場合には、例えばパウダ
ー・リキツド系のセメント材であれば、充填剤等
をパウダーの方に、防腐剤や消炎剤等をリキツド
の方に予め加えておくが如く、副次成分を予めセ
メント材の一方又は双方の保存系に適宜加えてお
くようにするか、或は双方の保存系を練合して使
用するときに副次成分を配合するようにすればよ
い。
本発明の歯科治療用セメント材は、以上述べた
ように、主成分がアルミナセメント粉であり、カ
ルシウム系粉末硬化剤を該セメント粉100重量部
に対し1〜50重量部の割合とすることによつて、
練合使用時に適度なアルカリ性を呈するようにし
たものであるから、このセメント材を根管充填剤
や歯髄覆罩剤として使用すると、この適度なアル
カリ性による抗菌作用及び治癒作用をよく発揮
し、しかも表面に水和ゲル組成を生じるため根管
壁や窩洞壁に対する良好な適合性、及び組織に対
する良好な親和性を示すのである。そして、硬化
遅延剤の割含を既述の如くアルミナセメント粉
100重量部に対し1〜20重量部とする場合には、
硬化時間が数分ないし数10分程度の取扱い易いセ
メント材となるのである。その上、本発明組成物
は毒性や刺激が殆んど無く、しかもその硬化物が
高強度にして体積変化を生じず、組織液にも不溶
であつて極めて耐久性に富んでおり、亦、歯科用
常温重合レジンの重合を阻害することもなく、更
に可撒性が良好であるから再治療も容易に行なえ
る、等の利点を有しており、歯科治療用セメント
材として充分満足しうるものである。
次に、実施例を挙げて本発明をより具体的に説
明する。
実施例 1
市販のアルミナセメント粉(Al2O3:80重量
%、CaO:20重量%)に20重量%の水酸化カルシ
ウムを加え、磁製ルツボ内で2時間混合して混合
粉末を調製した。次にポリビニルアルコールの4
重量%、6重量%、8重量%及び10重量%の4種
類の濃度が異なる水溶液を調製し、パウダー・リ
キツド系セメント材を得た。
次に混合粉末に対し各々の水溶液を下記第1表
に示す割合で添加練合し、それぞれの練合組成物
について、硬化時間、稠度、溶解性、PH変化、圧
縮強度及び細胞毒性度を測定した。その結果を第
1表に併記する。
尚、測定は次の方法で行なつたものである。
硬化時間:ADA−No.16
粘稠度:ADA−No.16
溶解度:ADA−No.8
PH変化:溶解度測定と同様の方法
圧縮強度:ADA−No.8
細胞毒性度:組織培養法
The present invention relates to a cement material for dental treatment, and more particularly to a cement material for dental treatment containing alumina cement as a main component and suitable for use as a pulp capping agent, root canal filling agent, sealing agent, bone defect repair agent, etc. . In the field of dental treatment, it is used as a root canal filling agent to cure infected root canals by occluding the pulp cavity after the pulp tissue has been removed, or as a pulp covering agent to protect the pulp during cavity formation. Various materials are used. However, the reality is that so far nothing has been found that is fully satisfactory. Now, using root canal filling materials as an example, materials suitable for this are generally non-irritating, non-toxic, have affinity with tissues and compatibility with the root canal wall, It has antibacterial or healing effects, is strong, does not cause volume changes, is insoluble in tissue fluids, is flexible and can be retreated, has contrast properties, and is easy to handle. The ideal is to satisfy certain conditions such as: Among these, the contrast property can be solved by mixing an appropriate contrast medium, but other conditions largely depend on the characteristics of the root canal filling material itself. For example, one of the typical root canal filling materials that has been widely used in the past is one that uses zinc oxide/eugenol-based materials, but since these are acidic materials, they are irritating and It has no healing properties. Another representative thing is
Some materials use calcium hydroxide materials, but these have low strength and are strongly alkaline, so they may damage tissues and deteriorate into calcium carbonate over time. In addition, root canal filling agents using formaldehyde-based materials or iodoform-based materials are also used, but each has advantages and disadvantages, and nothing that fully satisfies the above conditions has yet been developed. There isn't. The present invention was made in view of the above circumstances, and focused on the possibility of using industrial alumina cement, which was not anticipated by anyone involved in the dental field. This was a successful improvement of cement to make it suitable as a material for dental treatment. That is, the present invention comprises alumina cement powder, a calcium-based powder hardening agent in a proportion of 1 to 50 parts by weight per 100 parts by weight of this cement powder, and a hardening retarder capable of suppressing the diffusion of calcium ions as essential components. This is a cement material for dental treatment. The main component, alumina cement powder, is composed of calcium aluminate (CaO・Al 2 O 3 ) with a ratio of approximately 80% by weight of aluminum oxide and approximately 20% by weight of calcium oxide, and is similar to commercially available industrial cement. It is easily and inexpensively available. Further, the calcium-based powder hardening agent used in the present invention is, for example, a powder of calcium hydroxide, calcium chloride, or calcium oxide, and calcium hydroxide powder is particularly preferably used. As mentioned above, the amount of the calcium-based powder hardening agent needs to be 1 to 50 parts by weight per 100 parts by weight of the alumina cement powder. This is less than 1 part by weight,
It takes a long time for the cement material to harden and the strength of the hardened product decreases, making it unsuitable as a therapeutic material such as pulp capping agent or root canal filling agent. For example, the curing speed and alkalinity become too high, which has a negative effect on handling and healing effects. For this reason, when comparing and weighing curing time, strength, healing effect, etc., the proportion of calcium-based powder hardening agent should be
The optimal amount is about 20 parts by weight, and when this proportion is used, a cement material with great strength and healing effects and good handling properties can be obtained. On the other hand, the curing retarder used in the present invention is a low molecular weight compound such as polyvinyl alcohol, polyvinylpyrrolidone, gum arabic, sodium polyacrylate, sodium silicate, glycerin, etc. that can suppress the diffusion of calcium ions involved in the curing of alumina cement. A fatty acid or a hydrophilic natural resin,
These may be used alone or in combination of two or more. Such a hardening retarder is alumina cement powder 100
The ratio is preferably 1 to 20 parts by weight. If it is less than 1 part by weight, the curing retardation effect is insufficient and the cement material will harden in a very short period of time, whereas if it exceeds 20 parts by weight, the curing retardation effect will be excessive and it will not harden. This is because a long time is required, resulting in a composition that is unsuitable for dental treatment cement materials. The cement material of the present invention contains the above-mentioned alumina cement powder, calcium-based powder hardening agent, and hardening retardant as essential components, but if necessary,
For example, fillers such as titanium oxide powder and aluminum oxide powder are added to increase strength, and preservatives such as iodoform and polaform are added.
Of course, it is also possible to add various known contrast agents and antiinflammatory agents. There is no particular restriction on the ratio of such secondary components, and it may be determined as appropriate. The cement materials for dental treatment of the present invention as described above can be divided into the following four types depending on the storage form before use. The first type is a powder/liquid type that is stored separately into a mixed powder containing at least alumina cement powder and a calcium-based hardening agent, and a liquid in which at least a hardening retarder is dissolved or dispersed in water, etc. The second type of composition is stored separately into a powder containing at least alumina cement powder and a paste obtained by adding and kneading a calcium-based powder hardening agent to at least a solution or dispersion of a hardening retarder. The third type is a powder/paste type composition, and the third type is a paste made by adding and kneading at least alumina cement powder and a calcium-based powder hardening agent to glycerin or the like;
It is a paste/liquid type composition that is stored separately from a liquid in which at least a hardening retardant is dissolved or dispersed, and the fourth type is a paste made by adding and kneading at least alumina cement powder to glycerin or the like. It is a paste/paste type cement material that is stored separately from a paste made by adding and kneading a calcium-based powder hardening agent to at least a solution or dispersion of a hardening retarder. Therefore, when adding the above-mentioned subsidiary ingredients, for example, if it is a powder/liquid type cement material, fillers etc. should be added to the powder side and preservatives and anti-inflammatory agents etc. to the liquid side. As usual, it is best to add the secondary ingredients to one or both of the preservative systems of the cement material in advance, or to mix the secondary ingredients when mixing and using both preservative systems. Just do it. As described above, the cement material for dental treatment of the present invention has alumina cement powder as its main component, and the calcium-based powder hardening agent is contained in a proportion of 1 to 50 parts by weight based on 100 parts by weight of the cement powder. Then,
Since this cement material is designed to exhibit appropriate alkalinity when used as a mixture, when used as a root canal filling agent or pulp covering agent, this cement material exhibits antibacterial and healing effects due to its moderate alkalinity. Because it produces a hydrated gel composition on the surface, it exhibits good compatibility with root canal walls and cavity walls, and good affinity with tissues. Then, add a hardening retarder to the alumina cement powder as described above.
In case of 1 to 20 parts by weight per 100 parts by weight,
This makes it an easy-to-handle cement material that takes a few minutes to several tens of minutes to harden. Furthermore, the composition of the present invention has almost no toxicity or irritation, and its cured product has high strength, does not cause volume change, is insoluble in interstitial fluid, and is extremely durable. It has the advantages of not inhibiting the polymerization of room-temperature polymerized resins, and has good flexibility, making retreatment easy, and is therefore fully satisfactory as a cement material for dental treatment. It is. Next, the present invention will be described in more detail with reference to Examples. Example 1 20% by weight of calcium hydroxide was added to commercially available alumina cement powder ( Al2O3 : 80% by weight, CaO: 20% by weight) and mixed in a porcelain crucible for 2 hours to prepare a mixed powder. . Next, polyvinyl alcohol 4
Aqueous solutions having four different concentrations of 4% by weight, 6% by weight, 8% by weight and 10% by weight were prepared to obtain powder/liquid cement materials. Next, each aqueous solution was added and kneaded to the mixed powder in the proportions shown in Table 1 below, and the curing time, consistency, solubility, PH change, compressive strength, and cytotoxicity were measured for each kneaded composition. did. The results are also listed in Table 1. Incidentally, the measurement was carried out by the following method. Curing time: ADA-No.16 Consistency: ADA-No.16 Solubility: ADA-No.8 PH change: Same method as solubility measurement Compressive strength: ADA-No.8 Cytotoxicity: Tissue culture method
【表】【table】
【表】
実施例 2
実施例1で調整した混合粉末に対し、実施例1
で調製した6重量%、8重量%及び10重量%のポ
リビニルアルコール水溶液のそれぞれに50重量%
の酸化チタンを添加したものを、第2表に示す配
合で添加練合し、各練合物について実施例1と同
様の測定を行なつた。その結果を第2表に併記す
る。[Table] Example 2 For the mixed powder prepared in Example 1, Example 1
50% by weight in each of 6% by weight, 8% by weight and 10% by weight polyvinyl alcohol aqueous solutions prepared in
of titanium oxide was added and kneaded according to the formulation shown in Table 2, and the same measurements as in Example 1 were performed on each kneaded product. The results are also listed in Table 2.
【表】【table】
【表】
実施例 3
硬化遅延剤として、ポリビニルアルコールに代
えてポリビニルピロリドンと、アラビアゴムを使
用した以外は、実施例1と同様にしてパウダー・
リキツド系組成物を得、各々の測定を行なつた。
その結果を第3表に示す。但し、第3表中の測定
値は、いずれも得られた測定値を個々に表示しな
いで、最小値と最大値をとつて表示したものであ
る。[Table] Example 3 Powder was prepared in the same manner as in Example 1, except that polyvinylpyrrolidone and gum arabic were used instead of polyvinyl alcohol as the curing retarder.
A liquid composition was obtained and various measurements were performed.
The results are shown in Table 3. However, all of the measured values in Table 3 do not display the obtained measured values individually, but instead show the minimum and maximum values.
【表】【table】
【表】
以上の各実施例の測定結果から、本発明歯科治
療用セメント材は、硬化時間、稠度が適当であ
り、強度が大で溶解度が小さく、しかも適当なPH
値を有しており、亦毒性も極めて少ない有用なも
のであることが判る。[Table] From the measurement results of the above examples, the cement material for dental treatment of the present invention has an appropriate hardening time and consistency, high strength, low solubility, and has an appropriate pH.
It can be seen that it is a useful product with extremely low toxicity.
Claims (1)
量部に対し1〜50重量部の割合のカルシウム系粉
末硬化剤と、カルシウムイオンの拡散を制御し得
る硬化遅延剤とを必須成分とする歯科治療用セメ
ント材。 2 硬化遅延剤を、アルミナセメント粉100重量
部に対し1〜20重量部の割合とした特許請求の範
囲第1項記載のセメント材。 3 アルミナセメント粉及びカルシウム系粉末硬
化剤を少なくとも含む混合粉末と、少なくとも硬
化遅延剤を溶解もしくは分散させた液とから成
る、パウダー・リキツド系の特許請求の範囲第1
項又は第2項記載のセメント材。 4 アルミナセメント粉を少なくとも含む粉末
と、カルシウム系粉末硬化剤及び硬化遅延剤を少
なくとも含むペーストとから成る、パウダー・ペ
ースト系の特許請求の範囲第1項又は第2項記載
のセメント材。 5 アルミナセメント粉及びカルシウム系粉末硬
化剤を少なくとも含むペーストと、少なくとも硬
化遅延剤を溶解もしくは分散させた液とから成
る、ペースト・リキツド系の特許請求の範囲第1
項又は第2項記載のセメント材。 6 アルミナセメント粉を少なくとも含むペース
トと、カルシウム系粉末硬化剤及び硬化遅延剤を
少なくとも含むペーストから成る、ペースト・ペ
ースト系の特許請求の範囲第1項又は第2項記載
のセメント材。 7 硬化遅延剤として、ポリビニルアルコール、
ポリビニルピロリドン、アラビアゴム、ポリアク
リル酸ソーダ、ケイ酸ナトリウム、グリセリンそ
の他の低分子脂肪酸及び親水性天然樹脂よりなる
群から選ばれた一種又は二種以上を使用した特許
請求の範囲第1項乃至第6項のいずれかに記載の
セメント材。[Claims] 1 Alumina cement powder, a calcium-based powder hardening agent in a proportion of 1 to 50 parts by weight per 100 parts by weight of the cement powder, and a hardening retardant capable of controlling the diffusion of calcium ions as essential components. Cement material for dental treatment. 2. The cement material according to claim 1, wherein the curing retarder is contained in a proportion of 1 to 20 parts by weight per 100 parts by weight of alumina cement powder. 3. Claim 1 of a powder/liquid system consisting of a mixed powder containing at least an alumina cement powder and a calcium-based powder hardening agent, and a liquid in which at least a hardening retarder is dissolved or dispersed.
Cement material according to paragraph 2 or paragraph 2. 4. The cement material according to claim 1 or 2, which is a powder/paste type, comprising a powder containing at least alumina cement powder, and a paste containing at least a calcium-based powder hardening agent and a hardening retardant. 5. Claim 1 of a paste/liquid system consisting of a paste containing at least alumina cement powder and a calcium-based powder hardening agent, and a liquid in which at least a hardening retardant is dissolved or dispersed.
Cement material according to paragraph 2 or paragraph 2. 6. The paste-paste cement material according to claim 1 or 2, which is a paste-based cement material comprising a paste containing at least alumina cement powder and a paste containing at least a calcium-based powder hardening agent and a hardening retardant. 7 As a curing retarder, polyvinyl alcohol,
Claims 1 to 1 which use one or more selected from the group consisting of polyvinylpyrrolidone, gum arabic, sodium polyacrylate, sodium silicate, glycerin and other low molecular fatty acids, and hydrophilic natural resins. The cement material according to any of Item 6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56021686A JPS57134407A (en) | 1981-02-16 | 1981-02-16 | Basic material composition for dental treatment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56021686A JPS57134407A (en) | 1981-02-16 | 1981-02-16 | Basic material composition for dental treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57134407A JPS57134407A (en) | 1982-08-19 |
| JPS6332049B2 true JPS6332049B2 (en) | 1988-06-28 |
Family
ID=12061944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56021686A Granted JPS57134407A (en) | 1981-02-16 | 1981-02-16 | Basic material composition for dental treatment |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS57134407A (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61229806A (en) * | 1985-04-05 | 1986-10-14 | G C Dental Ind Corp | Dental aluminic acid cement composition |
| JPS61229807A (en) * | 1985-04-05 | 1986-10-14 | G C Dental Ind Corp | Dental cement composition |
| US4689080A (en) * | 1985-07-24 | 1987-08-25 | Haruyuki Kawahara | Base material composition for dental treatment |
| JPH04173713A (en) * | 1990-11-07 | 1992-06-22 | Sogo Shika Iryo Kenkyusho:Kk | Paste for dental glass ionomer cement |
| RU2696232C1 (en) * | 2018-06-26 | 2019-07-31 | федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Западный государственный медицинский университет им. И.И. Мечникова" Министерства здравоохранения Российской Федерации | Method of treating a bone defect experimentally |
-
1981
- 1981-02-16 JP JP56021686A patent/JPS57134407A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS57134407A (en) | 1982-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4689080A (en) | Base material composition for dental treatment | |
| EP2049067B1 (en) | Curable dental retraction composition, method of production and use thereof | |
| US4288355A (en) | Surgical cement composition | |
| EP3079645B1 (en) | Glass ionomer cement, process of production and use thereof | |
| JPS61229807A (en) | Dental cement composition | |
| CA2625143A1 (en) | Dental and endodontic filling materials and methods | |
| WO2008103712A2 (en) | Polymerizable dental pulp healing, capping, and lining material and method for use | |
| JPS632522B2 (en) | ||
| RU2197940C1 (en) | Material for filling root canals of teeth | |
| JPH04234305A (en) | Processable material and use thereof as filler for root channel of tooth | |
| JP2023159376A (en) | Glass ionomer cement composition for dental luting with good removability | |
| JPS6332049B2 (en) | ||
| JP7365776B2 (en) | Glass ionomer cement composition for dental luting with good removability | |
| Going et al. | Cements for permanent luting: a summarizing review | |
| JPS6219508A (en) | Root canal filling material for dental use | |
| US20040054027A1 (en) | Dental adhesive compositions with desensitizing agents | |
| JPH0324441B2 (en) | ||
| CN1088353C (en) | Moisturizing, powdered alginate impression material | |
| GB2094326A (en) | Resin-calcium hydroxide composite restorative dental material | |
| US20190046418A1 (en) | Dental cement composition | |
| JPS62153204A (en) | Root canal filling material for dental use | |
| JP2020522536A (en) | Flowable composition | |
| JPH02302409A (en) | Indicator-curable composition | |
| JP3891504B2 (en) | Dental light-curing filling material | |
| ES3021134T3 (en) | Dental product for forming an endodontic cement |